Pages that link to "Q71890854"
The following pages link to Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group (Q71890854):
Displaying 20 items.
- Bisphosphonates and other bone agents for breast cancer (Q24203656) (← links)
- Bisphosphonates for breast cancer (Q24246519) (← links)
- Bisphosphonates: mechanism of action and role in clinical practice (Q24644708) (← links)
- Drugs in development: bisphosphonates and metalloproteinase inhibitors (Q24795847) (← links)
- The present and future role of bisphosphonates in the management of patients with breast cancer (Q24802100) (← links)
- Actions of bisphosphonates in animal models of breast cancer (Q24802119) (← links)
- Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches (Q24806367) (← links)
- Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer (Q24811840) (← links)
- Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment (Q25255562) (← links)
- National consensus in China on diagnosis and treatment of patients with advanced breast cancer (Q26775621) (← links)
- Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases (Q26997330) (← links)
- Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside? (Q28068956) (← links)
- Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma (Q28081996) (← links)
- Long-term analgesic effect of clodronate in rodents (Q28165627) (← links)
- Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial (Q28269037) (← links)
- The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel (Q28362972) (← links)
- Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone (Q28742851) (← links)
- Regression modeling with recurrent events and time-dependent interval-censored marker data. (Q30885141) (← links)
- Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat. (Q31034846) (← links)
- Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial (Q32040849) (← links)